• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2018.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Anchiano Therapeutics Announces Pricing of USD 30.5 Million Initial Public Of
    February 12, 2019
    Anchiano Therapeutics files for USD 40m Nasdaq IPO
    January 8, 2019
    Alpha radiation startup eliminates 70% of cancerous tumors
    January 3, 2019
    Cannabis smart inhaler co Syqe Medical raises $50m
    December 31, 2018
    Anchiano Therapeutics Announces Initiation of Its Pivotal Codex Study of Inod
    December 18, 2018
    Anti-tumor DaRT could point the way to new arsenal in battle against cancer
    December 12, 2018
    Israeli Company Set To Begin Testing New Radiation Cancer Therapy
    November 26, 2018
    Israeli optimized therapeutics co PolyPid raises USD 15m
    November 8, 2018
    Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer C
    November 7, 2018
    Mapi Pharma raises USD 10m from Chinese investor
    November 5, 2018